DigiMarc Stock Rallies After Hours On Q4 Revenue Beat DMRC’s total revenue for the fourth quarter of 2025 was $8.9 million compared to $8.7 million for the fourth quarter of 2024.
Bumble Stock Is Rallying Today After Hours – What Is Causing The Bull Run? The company said it expects total revenue for Q1 2026 to be in the range of $209 million to $213 million. Analysts on average estimate revenue of $210 million.
Regenxbio Says Its Gene Therapy For Muscle Disorder Showed No Evidence Of Liver Injury In Study The investigational gene therapy RGX-202 exhibited a favorable safety profile with no serious adverse events and no evidence of liver injury, the company said.
Sable Offshore To Reportedly Get Trump Support Via Emergency Law To Restart Production A White House official said that any policy announcement would come directly from the president, as per a Bloomberg News report.
Domo Posted A Double Beat On Q4 Results — So Why Is The Street Slashing Targets? The cloud software company posted Q4 results on Tuesday, with revenue coming in at $79.6 million, higher than consensus estimates of $79.03 million.
ALDX Stock Garners Retail Interest: Investors Debate Dry Eye Treatment Approval Amid Long Wait The U.S. Food and Drug Administration is slated to rule on the company’s application seeking approval for Reproxalap by March 16.
Groupon Stock Fell 11% After Hours – Here’s Why The company said its revenue was $132.7 million in the fourth quarter 2025, below analyst expectations of $136.7 million, as per data from Fiscal.ai.
CRML Shares Breach $10 Mark On Rare Earth Project Acceleration In Greenland — How Much More Upside Does The Street See? Freedom Capital initiated coverage of Critical Metals with a ‘Buy’ rating and $15 price target, representing an upside of almost 50% from its current price levels.
ESPR Stock Falls After Esperion’s Mixed Q4 — Retail Remains Unfazed, Eyes ‘Massive’ Upcoming Catalysts Esperion reported earnings per share of $0.22 on revenue of $168.5 million, while Wall Street expected an EPS of $0.28 on revenue of $164.7 million.
ZVRA Stock Soars On Upbeat Q4 Results, Optimism For EMA Approval Of Niemann-Pick Disease Treatment For the fourth quarter, Zevra announced net revenue of $34.1 million, exceeding an analyst estimate of $28.05 million.
IBRX Stock Declines Pre-Market — ImmunityBio Resubmits Anktiva Application To FDA With Additional Data ImmunityBio stated that the application includes additional information requested by the FDA to support its supplemental BLA for papillary disease.
Small-Caps Shine as "Magnificent Seven" Lose Luster in 2026 Market Pivot In the first quarter of 2026, the financial markets have undergone a definitive "regime change" that many analysts are calling the "Great Convergence." After years of an increasingly narrow market led by a handful of mega-cap technology giants, the tide has finally turned. The iShares Russell 2000 ETF (
NYSE: IWM )
Webull Stock Continues Decline After Q4 Earnings Miss – What Does The Street Think? Rosenblatt lowered the firm's price target on Webull to $12 from $15 and kept a ‘Buy’ rating on the shares, per TheFly.
Webull Stock Falls As Q4 Profit Miss Disappoints Traders The company posted net income per ordinary share of $0.01 that was below Wall Street estimates of $0.05 per share as per data from Fiscal.ai.
Vanda Now Looks To Public Hearing For Hetlioz In Jet Lag Disorder After Multiple FDA Rejections According to Vanda, the FDA has not granted such a hearing in the context of drug approvals for potentially over 40 years.
Better iShares ETF: Large-Cap Exposure with IVV or Small-Cap Focused IWM Compare how cost, sector focus, and risk profiles set IVV and IWM apart for investors seeking different equity exposures.
